Stay updated on ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.

Latest updates to the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations have been updated and expanded to include sites across California, Florida, Illinois, New York, Pennsylvania, Tennessee, Texas, Virginia, Ontario, and Quebec, with a page revision to v3.3.3 and removal of the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page; no substantive changes to study details or related information are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedThe banner about government funding and operating status has been removed. The study details for NCT03821233 remain unchanged.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant changes observed; the study details, eligibility criteria, and layout appear unchanged between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference4%

- Check106 days agoChange DetectedPage version updated to v3.1.0; removal of the term 'Ovarian cancer' indicates a content refinement with no broader substantive changes.SummaryDifference0.2%

Stay in the know with updates to ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.